July 24, 2018
July 9, 2018
Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington’s Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
June 1, 2018
Oncternal Announces Publication of Data from Phase 1 Trial of Cirmtuzumab in CLL in Cell Stem Cell
May 3, 2018
SelectION Appoints Antonius Schuh as New CEO
December 12, 2017
Telephus Biosciences Appoints Patrick Vink, M.D., MBA, William Boyle, Ph.D., and Richard Proctor, M.D., as Company Advisors
November 17, 2017
Telephus Medical Founder Awarded $6 Million NIH Grant to Expand Translational Research in Bone Infections
November 16, 2017
Retrotope initiates second patient for Compassionate Use of RT001 for an ultrarare genetic neurological disease, Infantile Neuroaxonal Dystrophy.
October 4, 2017
Zavante Therapeutics Presents Additional Clinical and Microbiologic Data From ZOLYD™ Phase 2/3 Trial at ID Week 2017
September 8, 2017